Common Variation in the DIO2 Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Introduction: Animal studies suggest that up to 80% of intracellular T3 in the brain is derived from circulating T4 by local deiodination. We hypothesized that in patients on T4 common variants in the deiodinase genes might influence baseline psychological well-being and any improvement on combined T4/T3 without necessarily affecting serum thyroid hormone levels. Methods: We analyzed common variants in the three deiodinase genes vs. baseline psychological morbidity and response to T4/T3 in 552 subjects on T4 from the Weston Area T4 T3 Study (WATTS). Primary outcome was improvement in psychological well-being assessed by the General Health Questionnaire 12 (GHQ-12). Results: The rarer CC genotype of the rs225014 polymorphism in the deiodinase 2 gene (DIO2) was present in 16% of the study population and was associated with worse baseline GHQ scores in patients on T4 (CC vs. TT genotype: 14.1 vs. 12.8, P = 0.03). In addition, this genotype showed greater improvement on T4/T3 therapy compared with T4 only by 2.3 GHQ points at 3 months and 1.4 at 12 months (P = 0.03 for repeated measures ANOVA). This polymorphism had no impact on circulating thyroid hormone levels. Conclusions: Our results require replication but suggest that commonly inherited variation in the DIO2 gene is associated both with impaired baseline psychological well-being on T4 and enhanced response to combination T4/T3 therapy, but did not affect serum thyroid hormone levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 12×
“Each C allele was associated with a 49% increase in odds of being a HAD-D case (P 0.01) and as a result caseness was almost twice as great in subjects homozygous for the CC genotype as in subjects with the TT genotype (24 vs. 13%).”
BackgroundMethodInfluentialThe Validity of Two Versions of the GHQ in the WHO Study of Mental Illness in General Health Care
GOLDBERG, D. P., GATER, R., SARTORIUS, N., USTUN, T. B., PICCINELLI, M., GUREJE, O., & RUTTER, C. (1997) · Psychological Medicine · doi:10.1017/s0033291796004242 · Cited by 3,657 · cited 8×
“First Published Online February 3, 2009 For editorial see page 1521 Abbreviations: C, Cytosine; fT3, free T3; fT4, free T4; GHQ-12, General Health Questionnaire, 12-question version; HAD, Hospital Anxiety and Depression Scale questionnaire; SNP, single-nucleotide polymorphism; T, thymine; TSQ, thyroid symptom question…”
MethodInfluentialBianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 12×
“However, when analyzed T T 1 2 3 11 12 13 14 15 16 17 18 TC 1 2 3 11 12 13 14 15 16 17 18 C C 1 2 3 11 12 13 14 15 16 17 18 B – TSQ *p = 0.03 T T 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 TC 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 C C 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 C – Satisfaction *p = 0.02 T T 1 2 3 9 10 11 12 13 14 15 T C 1 2 3 9 10 11 1…”
BackgroundMethodInfluentialSelf-citationBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“However, although in the initial study of combination therapy (T4 and T3), patients treated with the combination appeared to have improved well-being (10), 10 subsequent larger studies failed to confirm this benefit (11–20) and in at least one case demonstrated a large and sustained placebo effect (18).”
BackgroundThyroid hormones, serotonin and mood: of synergy and significance in the adult brain
Bauer, M., Heinz, A., & Whybrow, P. C. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000963 · Cited by 370
Wekking, E. M., Appelhof, B. C., Fliers, E., Schene, A. H., Huyser, J., Tijssen, J. G. P., & Wiersinga, W. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02025 · Cited by 299
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296 · cited 2×
“Metaanalysis of these trials (21) showed no benefit from combination therapy and a carefully controlled study of overreplacement with T4 also failed to show benefit (22).”
BackgroundEscobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261 · cited 1×
“reported that it was not possible to normalize tissue levels of thyroid hormone (T4 and T3) by replacement with T4 alone (2, 3) or T3 alone (4).”
Background
Research works printed but not linked: 1
- Levitt, 2002, T4 plus T3 for hypothyroidism: a double-blind comparison with usual T4, 4
Cited by
Items 101–200 of 327
Ross, D. S. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13410 · Cited by 42
Gene–Culture Interactions: Toward an Explanatory Framework
Kwon, H., & Sasaki, J. Y. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108562140 · Cited by 41
Jonklaas, J., & Burman, K. D. (2016) · Thyroid® · doi:10.1089/thy.2015.0629 · Cited by 41
Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
Daniels, G. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00002-x · Cited by 42
New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism
McAninch, E. A., & Bianco, A. C. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00325-3 · Cited by 39
Guglielmi, R., Frasoldati, A., Zini, M., Grimaldi, F., Gharib, H., Garber, J. R., & Papini, E. (2016) · Endocrine Practice · doi:10.4158/ep161308.or · Cited by 39
Emerging roles of ER-resident selenoproteins in brain physiology and physiopathology
Jehan, C., Cartier, D., Bucharles, C., Anouar, Y., & Lihrmann, I. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102412 · Cited by 42
Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level
Jonklaas, J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000355 · Cited by 38
Quinque, E. M., Karger, S., Arélin, K., Schroeter, M. L., Kratzsch, J., & Villringer, A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.015 · Cited by 39
Emerging Therapies in Hypothyroidism
Bianco, A. C. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101007 · Cited by 44
Quinque, E. M., Villringer, A., Kratzsch, J., & Karger, S. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-68 · Cited by 36
T4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
Ahluwalia, R., Baldeweg, S. E., Boelaert, K., Chatterjee, K., Dayan, C., Okosieme, O., Priestley, J., Taylor, P., Vaidya, B., Zammitt, N., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14935 · Cited by 34
“52,53 However, one involved a small patient cohort ( n = 45) and neither provided robust statistical testing for multiple variants genotyped ( n = 16 and n = 4 SNPs).”
BackgroundSelf-citationThyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 35
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Van Tassell, B., Wohlford, G. F., Linderman, J. D., Smith, S., Yavuz, S., Pucino, F., & Celi, F. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0101 · Cited by 31
Hyperthyroidism and clinical depression: a systematic review and meta-analysis
Bode, H., Ivens, B., Bschor, T., Schwarzer, G., Henssler, J. F., & Baethge, C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02121-7 · Cited by 74
Axonal T3 uptake and transport can trigger thyroid hormone signaling in the brain
Salas-Lucia, F., Fekete, C., Sinkó, R., Egri, P., Rada, K., Ruska, Y., Gereben, B., & Bianco, A. C. (2023) · eLife · doi:10.7554/elife.82683 · Cited by 33
Thyroid Hormone Replacement Therapy: Three Simple Questions, Complex Answers
Bianco, A. C., & Casula, S. (2012) · European Thyroid Journal · doi:10.1159/000339447 · Cited by 32
Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Thyroid · doi:10.1089/thy.2018.0369 · Cited by 31
Midgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015) · Endocrine Connections · doi:10.1530/ec-150056 · Cited by 31
Rajput, R., & Pathak, V. (2017) · European Thyroid Journal · doi:10.1159/000477348 · Cited by 31
Determining minimal important change for the thyroid related quality of life questionnaire ThyPRO
Nordqvist, S. F., Boesen, V. B., Rasmussen, Å. K., Feldt-Rasmussen, U., Hegedüs, L., Bonnema, S. J., Cramon, P. K., Watt, T., Groenvold, M., & Bjorner, J. B. (2021) · Endocrine Connections · doi:10.1530/ec-21-0026 · Cited by 31
Dew, R., King, K., Okosieme, O. E., Pearce, S. H., Donovan, G., Taylor, P. N., Hickey, J., Dayan, C. M., Leese, G., Razvi, S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019970 · Cited by 31
Self-citationMedici, M., Visser, T. J., & Peeters, R. P. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.002 · Cited by 39
Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?
Michaelsson, L. F., la Cour, J. L., Medici, B. B., Watt, T., Faber, J., & Nygaard, B. (2018) · European Thyroid Journal · doi:10.1159/000490383 · Cited by 30
The Physiological Functions and Polymorphisms of Type II Deiodinase
Deng, Y., Han, Y., Gao, S., Dong, W., & Yu, Y. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1599 · Cited by 37
Kraut, E., & Farahani, P. (2015) · Clinical and Investigative Medicine · doi:10.25011/cim.v38i6.26194 · Cited by 30
Escobar-Morreale, H. F., Botella-Carretero, J. I., & Morreale de Escobar, G. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.10.004 · Cited by 30
Peltsverger, M. Y., Butler, P. W., Alberobello, A. T., Smith, S., Guevara, Y., Dubaz, O. M., Luzon, J. A., Linderman, J., & Celi, F. S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1073 · Cited by 29
Thyroid–Brain Interactions in Neuropsychiatric Disorders
Bunevičius, R., & Prange, A. J. (2010) · Springer eBooks · doi:10.1007/978-4-431-53871-4_2 · Cited by 28
Risks and safety of combination therapy for hypothyroidism
Jonklaas, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1182019 · Cited by 27
Medici, B. B., la Cour, J. L., Michaelsson, L. F., Faber, J. O., & Nygaard, B. (2017) · European Thyroid Journal · doi:10.1159/000454878 · Cited by 25
Critical Approach to Hypothyroid Patients With Persistent Symptoms
Biondi, B., Celi, F. S., & McAninch, E. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad224 · Cited by 34
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer
Hannoush, Z. C., & Weiss, R. E. (2016) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10229 · Cited by 34
Radioiodine Therapy for Hyperthyroidism
Villagelin, D., Santos, R. B., & Romaldini, J. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1103014 · Cited by 26
Mood Disorders in Levothyroxine-Treated Hypothyroid Women
Romero-Gómez, B., Guerrero-Alonso, P., Carmona-Torres, J. M., Notario-Pacheco, B., & Cobo-Cuenca, A. I. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234776 · Cited by 25
“It has been observed that individuals with the Thr92Ala deiodinase type 2 variant score worse in health questionnaires, even under levothyroxine treatment [49].”
BackgroundUpdate on the treatment of hypothyroidism
Jonklaas, J. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000242 · Cited by 27
Bunevičius, A., Gintauskienė, V. M., Podlipskytė, A., Žaliūnas, R., Brožaitienė, J., Prange, A. J., & Bunevičius, R. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318268e7f0 · Cited by 30
Subclinical Hypothyroidism and Depression: Is There a Link?
Samuels, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00276 · Cited by 48
Borson‐Chazot, F., Terra, J., Goichot, B., & Caron, P. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071386 · Cited by 37
The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy
McAninch, E. A., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00446 · Cited by 24
Patient Experiences and Perceptions Associated with the Use of Desiccated Thyroid Extract
Toloza, F. J. K., Espinoza Suarez, N. R., El Kawkgi, O., Golembiewski, E. H., Ponce, O. J., Yao, L., Maraka, S., Singh Ospina, N. M., & Brito, J. P. (2020) · Medicina · doi:10.3390/medicina56040161 · Cited by 22
“These polymorphisms have been linked in retrospective studies with patients’ self-reported preference with combined thyroid therapy [35,36].”
ResultJonklaas, J., Tefera, E., & Shara, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00031 · Cited by 23
Springer, D. (2012) · InTech eBooks · doi:10.5772/1215 · Cited by 26
Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder
Gałecka, E., Talarowska, M. E., Orzechowska, A., Górski, P., Bieńkiewicz, M., & Szemraj, J. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1002 · Cited by 25
CEP128 is a crucial risk locus for autoimmune thyroid diseases
Wang, B., Jia, X., Yao, Q., Li, Q., He, W., Li, L., Song, R., Zhang, J., & Zhang, J. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.017 · Cited by 23
Brigante, G., Santi, D., Boselli, G., Margiotta, G., Corleto, R., Monzani, M. L., Craparo, A., Locaso, M., Sperduti, S., Roy, N., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad172 · Cited by 23
The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype
Walsh, J. P., Berry, J. A., Liu, S., Panicker, V., Dayan, C. M., Brix, T. H., Hegedűs, L. D., Hou, P., Shi, B., & Morahan, G. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03970.x · Cited by 25
Self-citationCombination Thyroid Hormone Replacement; Knowns and Unknowns
Taylor, P. N., Eligar, V., Muller, I., Scholz, A., Dayan, C., & Okosieme, O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00706 · Cited by 21
Self-citationGenetic abnormalities in thyroid hormone deiodinases
Taylor, P. N., Peeters, R., & Dayan, C. M. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000180 · Cited by 20
Self-citationLee, K. W., Shin, Y., Lee, S., & Lee, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.803024 · Cited by 22
Concurrent TSHR mutations and DIO2 T92A polymorphism result in abnormal thyroid hormone metabolism
Park, E., Jung, J., Araki, O., Tsunekawa, K., Park, S. Y., Kim, J., Murakami, M., Jeong, S., & Lee, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-28480-0 · Cited by 19
Paschou, S. Α., Alevizaki, M. K., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., Perros, P., & Vryonidou, A. (2021) · HORMONES · doi:10.1007/s42000-021-00335-w · Cited by 20
Xu, M. K., Gaysina, D., Barnett, J. H., Scoriels, L., van de Lagemaat, L. N., Wong, A., Richards, M., Croudace, T. J., Jones, P. B., & the LHA genetics group (2015) · Translational Psychiatry · doi:10.1038/tp.2015.86 · Cited by 18
For Some, l-Thyroxine Replacement Might Not Be Enough: A Genetic Rationale
Kim, B. W., & Bianco, A. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0410 · Cited by 18
Optimal Hormone Replacement Therapy in Hypothyroidism - A Model Predictive Control Approach
Wolff, T. M., Dietrich, J. W., & Müller, M. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.884018 · Cited by 27
Selenium Deficiency and Thyroid Disease
Rayman, M. P., & Duntas, L. H. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_9 · Cited by 23
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
Madan, R., & Celi, F. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00371 · Cited by 18
Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients
Arici, M., Öztaş, E., Yanar, F., Aksakal, N., Özçınar, B., & Özhan, G. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0162 · Cited by 19
Clinical significance of type 2 iodothyronine deiodinase polymorphism
Maino, F., Cantara, S., Forleo, R., Pilli, T., & Castagna, M. G. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1523714 · Cited by 17
Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism
Penna, G., Salas-Lucia, F., Ribeiro, M. O., & Bianco, A. C. (2023) · Endocrine · doi:10.1007/s12020-023-03528-y · Cited by 20
Hypothyroidism and Thyroiditis
Brent, G. A., & Weetman, A. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00013-7 · Cited by 23
Identification of Resistance to Exogenous Thyroxine in Humans
Lacámara, N., Beatriz Lecumberri, S., Barquiel, B., Escribano, A., Casado, I. G., Álvarez‐Escolá, C., Blanquer, F. A., Morales, F., Alfayate, R., Bernal-Soriano, M. C., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0825 · Cited by 17
Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism?
Gomes-Lima, C., Wartofsky, L., & Burman, K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00856 · Cited by 15
“Similarly, patients with a rarer CC genotype of the rs225014 polymorphism in the deiodinase 2 gene showed a greater degree of improvement on T4/T3 therapy than on T4 monotherapy (17).”
BackgroundManaging symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15
Biondi, B., Pucci, M., Pontieri, G., Formisano, P., & Esposito, R. (2023) · Thyroid · doi:10.1089/thy.2023.0135 · Cited by 15
Does Combination T4 And T3 Therapy Make Sense?
McDermott, M. T. (2012) · Endocrine Practice · doi:10.4158/ep12076.ra · Cited by 18
Heald, A. H., Premawardhana, L., Taylor, P., Okosieme, O., Bangi, T., Devine, H., Livingston, M., Javed, A., Moreno, G. Y. C., Watt, T., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14967 · Cited by 14
Self-citationPandit, P., Galande, S., & Iris, F. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.83 · Cited by 15
Dharia, A., Desai, D., & Desai, K. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.02.005 · Cited by 18
Prevalence of Dio2(T92A) polymorphism and its association with thyroid autoimmunity.
Guerra, A., Sapio, M. R., Carrano, M., Stasi, V. D., Volpe, A., Murino, A., Izzo, G., & Vitale, M. (2013) · PubMed · doi:10.3275/8618 · Cited by 14
Yalakanti, D., & Dolia, P. B. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-015-0518-9 · Cited by 15
Cho, Y. Y., Kim, H. J., Jang, H. W., Kim, T. H., Ki, C., Kim, S. W., & Chung, J. H. (2017) · Endocrine · doi:10.1007/s12020-017-1307-4 · Cited by 17
Genetics and phenomics of selenoenzymes—How to identify an impaired biosynthesis?
Schomburg, L. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.011 · Cited by 14
de Lima Beltrão, F. E., de Almeida Beltrão, D. C., Carvalhal, G., de Lima Beltrão, F. E., de Souza Braga Filho, J., de Brito Oliveira, J., de Jesus, J. D. S., Machado, G. J. R., dos Santos Silva, H., Teixeira, H. M. P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac075 · Cited by 12
“In a large report that included approximately 550 LT4treated patients, the Thr92Ala-DIO2 polymorphism had no effect on the serum T4:T3 ratio (31), but in another series of 140 patients it was associated with a higher T4:T3 ratio (32).”
BackgroundWang, X., Chen, K., Zhang, C., Wang, H., Li, J., Wang, C., Teng, W., Shan, Z., & Lai, Y. (2021) · BioMed Research International · doi:10.1155/2021/9914009 · Cited by 13
Gałecka, E., Talarowska, M. E., Maes, M. H. J., Su, K., Górski, P., & Szemraj, J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.019 · Cited by 13
Thyroid dysfunction in the era of precision medicine
Galofré, J. C., Díez, J. J., & Cooper, D. S. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.04.009 · Cited by 11
A Step Forward in Understanding the Relevance of Genetic Variation in Type 2 Deiodinase
Medici, M., Chaker, L., & Peeters, R. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00585 · Cited by 11
Brožaitienė, J., Skiriutė, D., Burkauskas, J., Podlipskytė, A., Jankauskienė, E., Serretti, A., & Mickuvienė, N. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0283 · Cited by 11
Petnehazy, E., & Buchinger, W. (2019) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-019-0691-1 · Cited by 12
Dora, J. M., Wajner, S. M., Costa, J. D., Ribeiro, R. V. P., Leiria, L. B., Lopes, M. G. D. S. M., da Silva, A. V., Crispim, D., & Maia, A. L. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.018 · Cited by 11
Mols, F., Schoormans, D., Netea-Maier, R. T., Husson, O., Beijer, S., Deun, K. V., Zandee, W. T., Kars, M., Poppel, P. W., Şimşek, S., et al. (2023) · Thyroid Research · doi:10.1186/s13044-023-00165-5 · Cited by 10
Recent review on medical treatment of thyroid disease
Park, K. H., & Lee, E. J. (2012) · Journal of Korean Medical Association · doi:10.5124/jkma.2012.55.12.1207 · Cited by 10
Somppi, T. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00919 · Cited by 11
Riis, K. R., Larsen, C. B., & Bonnema, S. J. (2024) · Thyroid® · doi:10.1089/thy.2023.0649 · Cited by 10
“60,61 Only one study investigated whether improvement in QoL depended on the presence of this gene variant, but no such association was demonstrated.”
Cognitive function in hypothyroidism: what is that deiodinase again?
Hernández, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci125203 · Cited by 10
Gogakos, A. I., Logan, J. G., Waung, J. A., Bassett, J. H. D., Glüer, C., Reid, D. M., Felsenberg, D., Roux, C., Eastell, R., & Williams, G. R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1009 · Cited by 10
Hypothyroxinaemia and Brain Development
Lazarus, J. H., & Taylor, P. N. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.1 · Cited by 11
Brown, B. T., Graham, P. L., Bonello, R., & Pollard, H. P. (2015) · Chiropractic & Manual Therapies · doi:10.1186/s12998-015-0068-5 · Cited by 15
Functional Analysis of Novel Genetic Variation in the Thyroid Hormone Activating Type 2 Deiodinase
Zevenbergen, C., Klootwijk, W., Peeters, R. P., Medici, M., de Rijke, Y. B., Huisman, S. A., Goeman, H. J. M., Boot, E., de Kuijper, G. M., de Waal, K. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2281 · Cited by 11
Heim, M., Nixon, I. J., Emmerson, E., & Callanan, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.997288 · Cited by 13
Treatment of Hypothyroidism: Possibilities on the Horizon
Jonklaas, J., Burman, K. D., & Bianco, A. C. (2013) · Thyroid · doi:10.1089/thy.2013.0171 · Cited by 10
Hanif, F. M., Amir, Q., & Washdev, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031915 · Cited by 9
Zamar, A., Lulsegged, A., & Kouimtsidis, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.976544 · Cited by 8
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Hughes, D. A., Skiadas, K., Fitzsimmons, D. F., Anderson, P., & Heald, A. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051702 · Cited by 7
Nice guideline on thyroid disease: where does it take us with liothyronine?
Leese, G. (2020) · Thyroid Research · doi:10.1186/s13044-020-00081-y · Cited by 7
Welborn, T. A. (2013) · Endocrine Practice · doi:10.4158/endp.19.6.266x613757j22j36 · Cited by 7
Metadata
- Authors
- Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M.
- Affiliations
- The University of Western Australia (AU)
- University of Bristol (GB)
- Royal Devon and Exeter Hospital (GB)
- University of Exeter (GB)
- Corresponding author
- Dayan, Colin M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-05-01
- Volume
- 94
- Issue
- 5
- Pages
- 1623-1629
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2059487357
- Cited by
- 327
- References
- 39
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 10 · 2023: 23 · 2022: 27 · 2021: 23 · 2020: 15 · 2019: 25 · 2018: 22 · 2017: 21 · 2016: 25 · 2015: 22 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- deiodinase 2, triiodothyronine, thyroxine, hypothyroidism, combination thyroid hormone therapy, genetic polymorphism, psychological well-being, treatment response, GHQ-12, serum thyroid hormones
- MeSH terms
- Iodothyronine Deiodinase Type II, Adult, DNA, Female, Genotype, Health Status, Humans, Hypothyroidism, Iodide Peroxidase, Male, Polymorphism, Genetic, Predictive Value of Tests, Psychometrics, Surveys and Questionnaires, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine, Genetic Variation, Hormone Replacement Therapy, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.